Frontpage

Gefurulimab rapidly improved generalised myasthenia gravis symptoms and was well tolerated over 26 weeks.

3 Aug 2026

Gefurulimab Improved Generalised Myasthenia Gravis Symptoms

A nationwide Austrian study found that osteoporosis is often not coded alongside fragility fractures, especially upper limb breaks and in men.

3 Aug 2026

Osteoporosis Often Goes Unrecorded After Fragility Fractures

Dermatology

3 Aug 2026

Virtual Support Improved Quality of Life in Vulvar Lichen Sclerosus

Expert-led virtual support significantly improved quality of life in women with vulvar lichen sclerosus, supporting its role alongside medical therapy.

A large cohort study has found that diurnal salivary cortisol patterns were linked to cognitive decline in older adults.

3 Aug 2026

Salivary Cortisol Patterns May Predict Cognitive Decline

Oncology

3 Aug 2026

Remimazolam Strategy Improved Recovery After Breast Cancer Surgery

Remimazolam reduced recovery times without increasing PONV risk after breast cancer surgery in a randomised trial. Read more.

Respiratory

3 Aug 2026

Pre-Tracheostomy Feeding Does Not Increase Aspiration Risk

A prospective study found that continuing enteral nutrition before tracheostomy did not significantly increase aspiration pneumonia or worsen outcomes in ICU patients.

Patients with IBD had altered bile acid profiles, reduced TGR5 activation and lower microbial bile acid transformation, which correlated with increased inflammatory activity.

2 Aug 2026

Mismatched Donor Transplants Reduced Relapse Risk

Gastroenterology

2 Aug 2026

Inflammatory Bowel Disease Linked to Reduced TGR5 Activation

Oncology

2 Aug 2026

Smoking Cessation in Cancer Care Should Become Standard Treatment

Clinicians should not assume patients diagnosed with cancer will quit smoking without help, with new guidance urging routine access to evidence-based smoking cessation treatment.

Latest in your therapy area

Allergy & Immunology

Antiepileptic Drugs Accounted for Quarter of SJS/TEN Cases

Cardiology

Reinforcement Learning Improves Coronary Artery Disease Decisions

Dermatology

Virtual Support Improved Quality of Life in Vulvar Lichen Sclerosus

Diabetes

PMOS Linked to Harmful Cholesterol Subclasses in Type 1 Diabetes

EMJ GOLD

12 years after Pfizer, AstraZeneca reaches for BMS

Flagship Journal

EASL 2026 Interview: Ana Lleo

Gastroenterology

Inflammatory Bowel Disease Linked to Reduced TGR5 Activation

General Healthcare

Screen Time Linked to Poorer Skin and Body Image

Hematology

Mismatched Donor Transplants Reduced Relapse Risk

Hepatology

Liver Transplant Disparities Persist Despite Rising LDLT Rates

Innovations

From Innovation to Impact in Digital Health: Interview with Lloyd Humphreys

Interventional Cardiology

Echocardiography Optimises Transcatheter Tricuspid Interventions

Microbiology & Infectious Diseases

Vibrio vulnificus Cases Rise Across Florida

Nephrology

Recurrent IgA Nephropathy Risks Identified After Transplantation

Neurology

Gefurulimab Improved Generalised Myasthenia Gravis Symptoms

Oncology

Remimazolam Strategy Improved Recovery After Breast Cancer Surgery

Radiology

U-I-P Score Predicted Disease Progression in Smokers with Fibrotic IIP

Reproductive Health

Drinking Water Chemicals Linked to Risk of Uterine Cancer

Respiratory

Pre-Tracheostomy Feeding Does Not Increase Aspiration Risk

Rheumatology

Osteoporosis Often Goes Unrecorded After Fragility Fractures

Urology

Revolutionising Prostate Cancer Diagnosis

Respiratory

17 Jul 2026

Extracorporeal CO₂ Removal in Clinical Practice

This interactive case study allows clinicians to examine a patient with COPD presenting with an acute exacerbation…

General Healthcare

10 Jul 2026

The European Clinician's Guide to AI Tools

Explore approved AI tools for EU and UK clinicians in 2026, with evidence, CE/MHRA status, and practical guidance across specialties.

Urology

8 Jul 2026

Cardiovascular Risk and ADT in Prostate Cancer

This infographic is sponsored by Accord Healthcare and it’s intended for Health Care Professionals only

Explore how to integrate clinical and biomarker assessments to make an accurate diagnosis of Alzheimer’s disease in the earliest stages, and..

25 Jun 2026

Biomarkers & Beyond: Diagnosing Alzheimer’s

All Interactive Content

Latest Journals

All Journals

We are delighted to announce the release of the latest EMJ Hematology journal! Inside this issue, you will find a variety of content…

July 2026

EMJ Hematology 14.1 2026

We are delighted to announce the release of the latest EMJ Allergy & Immunology journal. Inside this issue, you will find a variety of…

July 2026

EMJ Allergy & Immunology 11.1 2026

We are delighted to announce the release of the latest edition of EMJ Rheumatology. In this issue, you will find a wealth of expert-led…

July 2026

EMJ Rheumatology 13.1 2026

Nephrology

July 2026

EMJ Nephrology 14.1 2026

We are delighted to announce the release of the latest EMJ Nephrology journal! Inside this issue, you will find a variety of content…

Congress Reviews

All Congress Reviews

I think what we’ve really been seeing is a rapid shift in the field, moving out of the direct research space and into something that is…

3 Mins

30 Jul 2026

AAIC 2026 Interview: Rebecca Edelmayer

The purpose of the ICNMD, which is part of the World Federation of Neurology (WFN), is to foster and promote neuromuscular disease…

7 Mins

29 Jul 2026

ICNMD 2026 Interview: Wolfgang Grisold

Abstracts

All Abstracts

5 Mins

23 Jul 2026

EHA 2026 Abstract Highlights

2 Mins

23 Jul 2026

Clustering Tree Allergens Reveals Immunotherapy-Relevant Profiles

Microbiology & Infectious Diseases

1 Mins

23 Jul 2026

Endovascular Profiles in ACE Inhibitor-Induced Angioedema in a South African Cohort

Latest Infographics

All Infographics

29 Jul 2026

Balancing speed and stewardship in AMR

In the UK, Fetcroja® (Cefiderocol) is indicated for the treatment of infections due to aerobic Gram-negative organisms in adults with…

Microbiology & Infectious Diseases

28 Jul 2026

Overcoming Cefiderocol AST Challenges in MDR-GN Infections: A Stepwise Approach

Inappropriate and delayed appropriate antibiotic therapy has a major impact on survival.1,2Antimicrobial susceptibility results obtained as…

This infographic explores the current impact and future potential of bispecific antibodies in haematological malignancies…

23 Jul 2026

Bispecific Antibodies for Haematologic Malignancies

This infographic presents the current landscape of functional neurological disorder care, where advances in classification, diagnosis…

22 Jul 2026

Functional Neurological Disorder: Modern Diagnosis and Management

Latest Podcasts

All Podcasts

Urology

3 Aug 2026

Revolutionising Prostate Cancer Diagnosis

In this series, host Catherine Glass speaks with Veeru Kasivisvanathan about the transformation of prostate cancer diagnosis. From MRI-first…

Oncology

3 Aug 2026

Onc Now: What Comes Next in Breast Oncology?

In this episode of Onc Now, Sara Hurvitz reflects on her career in breast oncology and discusses the major advances that have reshaped…

This episode explores new insights into first-line conventional treatments for rheumatoid arthritis, including optimising methotrexate…

30 Jul 2026

First-Line RA Treatments

In this episode, host Anna Caldwell speaks with Zachary Rubin about the growing impact of medical misinformation and vaccine hesitancy on public health.

30 Jul 2026

Vaccines and Medical Misinformation in the Social Media Age

Latest Videos & Webinars

All Videos & Webinars

The latest European Alliance of Associations for Rheumatology (EULAR)/ Paediatric Rheumatology European Society (PReS) recommendations on…

27 Jul 2026

Expert Insights on the Management of Still’s Disease

Nicola Conran shares insights from EHA 2026 on emerging therapies, gene editing, inflammation, and the evolving treatment landscape in sickle cell disease.

24 Jul 2026

Quickfire Q&A: Nicola Conran